Iovance Biotherapeutics Inc

NAS:IOVAHealthcareCBOEFTSE:MRUTNASDAQ:NBI

$14.86+4.57%At closeAt close · Wed 21 Oct · ≈ AED 54.57 · Market cap $6.73B · Next earnings Thu 5 Nov · Extended $14.88 +0.13%

Iovance Biotherapeutics Inc · Forecasts · TradingHolo

As of Tue 20 Oct

8 buy2 hold0 sell

Strong Buy consensus · 10 analysts

Average · last_month$10.00 −32.7%

Analysts3

Average · last_quarter$8.00

Average · last_year$7.00

Average · all_time$14.12

EPS actual vs estimate, last 8 reports

Analyst consensus · USD

Fiscal period	Revenue	EPS	Net income	Analysts
Thu, 31 Dec 2026	$362.4M$355.21M – $371.79M	−$0.5684−$0.6821 – −$0.3790	−$189.59M	6

Actual vs consensus

Report	EPS est.	Actual	Surprise	Revenue est.	Revenue
Thu, 6 Aug 2026	−$0.1335	−$0.1051	+21.2%	$87.83M	$99.31M
Thu, 7 May 2026	−$0.1900	−$0.1900	+0.0%	$77.84M	$71.43M
Tue, 24 Feb 2026	−$0.2200	−$0.1800	+18.2%	$80.71M	$86.71M
Thu, 6 Nov 2025	−$0.2900	−$0.2500	+13.8%	$82.17M	$67.46M
Thu, 7 Aug 2025	−$0.2900	−$0.3300	−13.8%	$78.32M	$59.95M
Thu, 8 May 2025	−$0.2500	−$0.3600	−44.0%	$82.37M	$49.32M
Thu, 27 Feb 2025	−$0.2600	−$0.2600	+0.0%	$72.17M	$73.69M
Thu, 7 Nov 2024	−$0.3100	−$0.2800	+9.7%	$71.57M	$58.55M